Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

Схожие документы

• The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
  по: Kow, Chia Siang, et al.
  Опубликовано: (2021)
• The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis
  по: Kow, Chia Siang, et al.
  Опубликовано: (2021)
• A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
  по: Kow, Chia Siang, et al.
  Опубликовано: (2021)
• The use of antimotility drugs in COVID-19 associated diarrhea
  по: Kow, Chia Siang, et al.
  Опубликовано: (2021)
• Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis
  по: Kow, Chia Siang, et al.
  Опубликовано: (2021)